AWM
ENTX icon

Altium Wealth Management’s Entera Bio ENTX Stock Holding History

Altium Wealth Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$16K Hold
11,830
– – ﹤0.01% 371
2022
Q1 		$34K Hold
11,830
– – ﹤0.01% 370
2021
Q4 		$33K Buy
+11,830
New +$44.3K ﹤0.01% 384

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Altium Wealth Management's ENTX Position: Q2 2022 in Review

Altium Wealth Management held its Entera Bio (ENTX) position steady in Q2 2022 at 11,830 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Altium Wealth Management first reported a position in ENTX in Q4 2021 and has held it in 3 quarters since. The position peaked at $34K in Q1 2022. 10 funds tracked by Wall St. Rank hold ENTX as of Q2 2022.

  • Altium Wealth Management held 11,830 shares of Entera Bio worth $16K as of Q2 2022.
  • Altium Wealth Management left its Entera Bio share count unchanged in Q2 2022.
  • Entera Bio made up ﹤0.01% of Altium Wealth Management's portfolio in Q2 2022, its #371 holding.
  • Altium Wealth Management first reported a position in Entera Bio in Q4 2021 and has held it in 3 quarters since.
  • Altium Wealth Management's Entera Bio position peaked at $34K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Entera Bio as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.